How many clicks is the 1.7mg Wegovy dose?

Why does the 1.7mg dose produce 68 clicks rather than a simpler number?

Wegovy pens use a uniform click increment of 0.025mg across every dose step in the titration ladder. The arithmetic is consistent: 0.025mg multiplied by 68 gives exactly 1.7mg. This increment was set by Novo Nordisk in the pen's engineering, and it means none of the doses land on a tidy multiple of ten. The 2.4mg maintenance dose, for comparison, takes 96 clicks, also not a round figure, for the same reason.

The click sound and feel serve a practical purpose: they give patients tactile and auditory feedback that the injection is progressing. Some people count clicks consciously during early doses while they get used to the process, though the pen's built-in counter is the authoritative reference. If you lose count mid-injection, the counter on the pen face is the reliable guide, not memory. For a detailed visual breakdown of each dose step against its click count, the 1.7mg Wegovy click chart on our site maps the relationship clearly.

Worth knowing: the pen itself is a single-dose format, pre-set at the factory. There is no user-adjustable dial. Each pen in a monthly supply is pre-filled and pre-set to the dose your prescriber has approved for that month of treatment, you cannot run a pen a few clicks short to "save" medicine, and you cannot get extra from a pen already emptied.

What does reaching 1.7mg mean in the Wegovy titration schedule?

Wegovy's standard titration runs: 0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg, with roughly four weeks at each step before moving up. Reaching 1.7mg means a patient has already spent around twelve weeks on the injection and has tolerated three earlier dose levels. It is the penultimate rung before the licensed maintenance dose of 2.4mg, and for most people it represents a point at which appetite suppression is well established and the body has had substantial time to adapt to semaglutide.

Some patients stay at 1.7mg longer than four weeks if side effects at that level need more time to settle, a decision made by the prescriber, not the patient. Others may remain at 1.7mg as their long-term dose if 2.4mg causes persistent side effects their prescriber judges outweigh the benefit of the higher dose. The full Wegovy dose guide explains each step and what drives the decision to progress or hold.

One practical timing note: the four-week cadence means a dose-step change often falls mid-month, around the time a repeat order is placed, occasionally clashing with a bank holiday or payday cycle. If you think your next supply and your dose-step date are going to collide, flag it with your prescriber or pharmacy before it becomes an issue, not after. The right dose needs to be dispensed before you inject it.

What should the injection feel like at 68 clicks, and what are the common side effects at this dose?

The physical sensation of a 1.7mg Wegovy injection is not noticeably different from lower doses, the pen's needle is the same gauge throughout the titration schedule, and the volume injected is small. Patients typically hold the pen firmly against the skin of the abdomen, thigh or upper arm for the duration of the click sequence, then hold for an additional ten seconds before withdrawing. If you are moving up from the previous step, our guide to Wegovy at the 1mg dose and its click count is a useful reference for how that transition feels in practice. The 1.7mg Wegovy guide covers injection technique in more detail.

Side effects at 1.7mg are predominantly gastrointestinal. Nausea is the most commonly reported, along with loose stools, reduced appetite beyond what patients experienced at lower doses, occasional vomiting and, for some, reflux or belching. These effects tend to be most pronounced in the first week or two after a dose increase and usually ease as the body adjusts. Fatigue and mild headache are also reported by some patients, particularly in the days immediately after a new dose.

Serious effects are infrequent but worth knowing. Severe, persistent abdominal pain that radiates toward the back (especially with vomiting) should prompt urgent medical attention; pancreatitis is a known, uncommon risk with GLP-1 medicines, and the MHRA Yellow Card scheme is the right route to report any suspected serious reaction. Signs of an allergic reaction (swelling, rash, difficulty breathing) also warrant emergency care. If you are uncertain whether a symptom is serious, contacting your prescriber is always the right first step rather than waiting to see.

Can you adjust the click count yourself to manage side effects at 1.7mg?

No. This is one of the most common questions the clinical team at our prescribers fields, and the answer is straightforward: the 1.7mg pen is not adjustable. Each pen is manufactured and calibrated to deliver exactly 68 clicks at 0.025mg each, and our page covering Wegovy at 1.7mg and how those 68 clicks are structured explains the engineering behind that figure in full. There is no mechanism to deliver 34 clicks and call it 0.85mg, nor any safe way to attempt a partial injection. Altering the dose outside what the pen is designed to do risks incorrect dosing, a contaminated needle tip or an air bubble affecting the next use, none of which are acceptable risks.

If nausea or other side effects at 1.7mg feel unmanageable, the right course is to speak with your prescriber. Clinically, the options include extending the time at 1.7mg before stepping up to 2.4mg, stepping back to 1.0mg temporarily, or pausing and restarting with a fresh plan. These are medical decisions, not self-management ones. For a broader look at how treatment fits together, the Wegovy overview on our site explains the clinical rationale behind how these medicines are prescribed in the UK. If you are considering starting Wegovy and want to understand whether it might suit your situation, checking your eligibility with our prescribers is a useful first step.